Abstract
Human paraoxonase 1 (huPON1) is a calcium-dependent esterase responsible for hydrolysis of a wide variety of substrates including organophosphates, esters, lactones, and paraoxon. Although its natural substrate is unknown, the action of PON as an antioxidant is well documented. Because recent reports have suggested glycation may induce reduced PON activity in diabetes, we investigated the structural features of huPON1 and its glycated mutant by template-based modeling, docking, and molecular dynamics (MD) simulations. Our results corroborated the importance of the His115–His134 dyad in both the lactonase and paraoxonase activity of huPON1. Structural alterations in the glycated model reflected weak interactions between the docked substrate and the active site cleft. We also used MD simulation to gain insight into glycation-induced conformational changes of huPON1 and the implication of this on depleted enzymatic activity. The catalytic calcium found on the surface interacts with the side chain oxygen of residues, including Asn224, Asn270, Asn168, Asp269, and Glu53, and this interaction with the respective residues undergoes minor displacement on glycation. The root-mean-square fluctuation had high motional flexibility in the non-glycated model whereas the conformation of the glycated structure was comparatively stable. Our findings emphasize the consequence of glycation-induced alterations and their effect on overall enzymatic activity.
Similar content being viewed by others
References
Altschul SF, Adden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25:3389–3402. doi:10.1093/nar/25.17.3389
Azam SS, Hofer TS, Randolf BR, Rode BM (2009) Hydration of sodium(I) and potassium(I) revisited: a comparative QM/MM and QMCF MD simulation study of weakly hydrated ions. J Phys Chem A 113:1827–1834. doi:10.1021/jp8093462
Bairoch A, Apweiler R (1996) The SWISS-PROT protein sequence data bank and its new supplement TREMBL. Nucleic Acids Res 24:21–25. doi:10.1093/nar/24.1.21
Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9. doi:10.2337/diabetes.48.1.1
Berendsen HC, Postma JPM, van Gunsteren WF, Dinola A, Haak JR (1984) Molecular dynamics with coupling to an external bath. J Chem Phys 81:3684–3690. doi:10.1063/1.448118
Billecke S, Draganov D, Counsell R, Stetson P, Watson C, Hsu C, La Du BN (2000) Human serum paraoxonase (pon1) isozymes Q and R hydrolyze lactones and cyclic carbonate esters. Drug Metab Dispos 28:1335–1342
Broomfield CA, Ford KW (1991) Hydrolysis of nerve gases by plasma enzymes. In: Proceedings of the 3rd international meeting on cholinesterases La Grande-Motte France, pp 161
Case DA et al (2008) AMBER 10. University of California, San Francisco
Davies HG, Richter RJ, Keifer M, Broomfield CA, Sowalla J, Furlong CE (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nat Genet 14:334–336. doi:10.1038/ng1196-334
Dhalla NS, Temsah RM, Netticadan T (2000) Role of oxidative stress in cardiovascular diseases. J Hypertens 18:655–673. doi:10.1097/00004872-200018060-00002
Eckerson HW, Swendris R, Smolen A, La Du BN (1982) A quantitative analysis of the calcium requirement of the human serum paraoxonase/arylesterase. Pharmacologist 24:232
Gohlke H, Hendlich M, Klebe G (2000) Knowledge-based scoring function to predict protein-ligand interactions. J Mol Biol 295:337–356. doi:10.1006/jmbi.1999.3371
Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RB, McCarthy A, Toker L, Silman I, Sussman JL, Tawfik DS (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11:412–419. doi:10.1038/nsmb767
Hashim Z, Zarina S (2007) Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract. Clin Biochem 40:705–709. doi:10.1016/j.clinbiochem.2007.03.015
Hashim Z, Ilyas A, Saleem A, Salim A, Zarina S (2009) Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radic Biol Med 46:1089–1095. doi:10.1016/j.freeradbiomed.2009.01.012
Hedrick CC, Thorpe SR, Fu MX, Harper CM, Yoo J, Kim SM, Wong H, Peters AL (2000) Glycation impairs high-density lipoprotein function. Diabetologia 43:312–320. doi:10.1007/s001250050049
Hu X, Jiang X, Lenz DE, Cerasoli MD, Wallqvist A (2009) In silico analyses of substrate interactions with human serum paraoxonase 1. Proteins 75:486–498. doi:10.1002/prot.22264
Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33–38. doi:10.1016/0263-7855(96)00018-5
Josse D, Lockridge O, Xie W, Bartels CF, Schopfer LM, Masson P (2001) The active site of human paraoxonase (PON1). J Appl Toxicol 21:7–11. doi:10.1002/jat.789
Khersonsky O, Tawfik SD (2006) The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J Biol Chem 281:7649–7656. doi:10.1074/jbc.M512594200
Kramer B, Rarey M, Lengauer T (1999) Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 37:228–241. doi:10.1002/(SICI)1097-0134(19991101)37:2<228:AID-PROT8>3.0.CO;2-8
Kuo CL, La Du BN (1995) Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 23:935–944
Kuo CL, La Du BN (1998) Calcium binding by human and rabbit serum paraoxonases. Structural stability and enzymatic activity. Drug Metab Dispos 26:653–660
Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283–291. doi:10.1107/S0021889892009944
Liu Y, Mackness B, Mackness M (2008) Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress. Free Radic Biol Med 45:743–748. doi:10.1016/j.freeradbiomed.2008.05.024
Lu YS, Jiang JY, Lv J, Wu XT, Yu SQ, Zhu WL (2010) Molecular docking and molecular dynamics simulation studies of GPR40 receptor-agonist interactions. Mol Graph Model 28:766–774. doi:10.1016/j.jmgm.2010.02.001
Mackness MI (1989) Possible medical significance of human serum ‘A’- esterases. In: Reiner E, Aldridge WN, Hoskin FCG (eds) Enzymes hydrolysing organophosphorus compounds. Ellis Horwood Ltd Publishers, Chichester, pp 202–213
Ng CJ, Wadleigh DJ, Gangopadhyay A, Hama S, Grijalva VR, Navab M, Foqelman AM, Reddy ST (2001) Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 276:44444–44449. doi:10.1074/jbc.M105660200
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM et al (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi:10.1002/jcc.20084
Primo-Parmo SL, Sorenson RC, Teiber J, La Du BN (1996) The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33:498–507. doi:10.1006/geno.1996.0225
Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470–489. doi:10.1006/jmbi.1996.0477
Reddy ST, Wadleigh DJ, Grijalva V, Ng C, Hama S, Ganqopadhyay A, Shih DM, Lusis AJ, Navab M, Foqelman AM (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542–547. doi:10.1161/01.ATV.21.4.542
Ryckaert JP, Ciccotti G, Berendsen JC (1977) Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Compu Phys 23:327–341. doi:10.1016/0021-9991(77)90098-5
Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815. doi:10.1006/jmbi.1993.1626
Shih DM, Gu L, Xia LYR, Navab M, Li WF, Hama S, Castellani LW, Furlong CE, Costa LG, Foqelman AM, Lusis AJ (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394:284–287. doi:10.1038/28406
Upham BL, Wagner JG (2001) Toxicant-induced oxidative stress in cancer. Toxicol Sci 64:1–3
Vinson JA (2006) Oxidative stress in cataracts. Pathophysiology 13:151–162. doi:10.1016/j.pathophys.2006.05.006
Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Prot Eng 8:127–134. doi:10.1093/protein/8.2.127
Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(Suppl 2):W407–W410. doi:10.1093/nar/gkm290
Acknowledgments
Financial support provided by Higher Education Commission, Pakistan, (grant no. 20-752) is gratefully acknowledged. The authors are grateful to David M. Case and his team for providing the license for the Amber 10 software.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saleem, A., Azam, S.S. & Zarina, S. Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1. Eur Biophys J 41, 241–248 (2012). https://doi.org/10.1007/s00249-011-0779-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00249-011-0779-z